{
    "clinical_study": {
        "@rank": "63620", 
        "arm_group": [
            {
                "arm_group_label": "Loss of pace capture", 
                "arm_group_type": "Active Comparator", 
                "description": "Pulmonary vein isolation: Ablation along the ablation line is continued until loss of pace capture along the ablation line is achieved"
            }, 
            {
                "arm_group_label": "Conventional", 
                "arm_group_type": "Active Comparator", 
                "description": "Pulmonary vein isolation: Ablation is discontinued when electrical isolation of the pulmonary veins is achieved."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study was to assess the near-term (12 months) efficacy of pulmonary vein\n      isolation using a standard approach compared to application of an additional acute\n      procedural endpoint of unexcitability along the ablation line."
        }, 
        "brief_title": "Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Paroxysmal Atrial Fibrillation", 
            "Catheter Ablation Strategies"
        ], 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  written informed consent\n\n          -  age > 18 years\n\n          -  paroxysmal atrial fibrillation\n\n        Exclusion Criteria:\n\n          -  structural heart disease\n\n          -  intracardiac thrombus\n\n          -  reversible causes of atrial fibrillation\n\n          -  inability to take warfarin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01724437", 
            "org_study_id": "PV3503"
        }, 
        "intervention": {
            "arm_group_label": [
                "Loss of pace capture", 
                "Conventional"
            ], 
            "description": "catheter based ablation using irrigated catheters and radiofrequency energy as in clinical practice", 
            "intervention_name": "catheter based pulmonary vein isolation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 8, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hamburg", 
                    "country": "Germany", 
                    "zip": "20246"
                }, 
                "name": "University Hospital Hamburg"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "recurrence of AF as assessed by 3 day holter monitoring", 
                "measure": "time to AF recurrence", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "assessment of AT recurrence using 3 day holter monitoring", 
                "measure": "time to AT recurrence", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01724437"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e4tsklinikum Hamburg-Eppendorf", 
            "investigator_full_name": "Dr. med. Daniel Steven", 
            "investigator_title": "Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "time needed to complete the procedure", 
                "measure": "procedure duration", 
                "safety_issue": "No", 
                "time_frame": "completed (15 months)"
            }, 
            {
                "description": "complication such as groin hematoma, stroke and pericardial bleed prolonging the hospital stay will be assessed", 
                "measure": "procedure safety", 
                "safety_issue": "Yes", 
                "time_frame": "up to three days after the procedure"
            }
        ], 
        "source": "Universit\u00e4tsklinikum Hamburg-Eppendorf", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e4tsklinikum Hamburg-Eppendorf", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}